Skip to content

NGNE

Neurogene Inc.

NASDAQ · Healthcare · Biotechnology · US

$38.60
+2.63%
Ask drillr
0
Insider buys (3m)
5
Insider sells (3m)
-$340.0K
Net value (3m)
+44.8%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Jul 7, 2026Cvijic Christine Mikail · director, officer: President and CFOSale600$36
Jul 7, 2026Cvijic Christine Mikail · director, officer: President and CFOSale4,200$36
Jul 2, 2026Cvijic Christine Mikail · director, officer: President and CFOSale739$34
Jul 2, 2026Cvijic Christine Mikail · director, officer: President and CFOSale2,531$35
Jul 2, 2026Cvijic Christine Mikail · director, officer: President and CFOSale1,530$35
Jun 16, 2026Woods Keith · directorA-Award7,700$43
Jun 16, 2026Woods Keith · directorA-Award15,400$32
Jun 16, 2026Woods Keith · directorA-Award12,050$20
May 8, 2026Cvijic Christine Mikail · director, officer: President and CFOSale4,800$30
May 7, 2026Shafer Christina · officer: Chief Commercial OfficerA-Award120,000$29
Mar 30, 2026Cvijic Christine Mikail · officer: President and CFOSale2,558$22
Mar 30, 2026McMinn Rachel · director, officer: Chief Executive OfficerSale3,352$22
Mar 30, 2026Jordan Julie · officer: Chief Medical OfficerSale828$22
Mar 17, 2026Cvijic Christine Mikail · officer: President and CFOSale1,395$21
Mar 17, 2026Cvijic Christine Mikail · officer: President and CFOSale263$22
Mar 17, 2026Cobb Stuart · officer: Chief Scientific OfficerSale3,991$20
Mar 17, 2026Cobb Stuart · officer: Chief Scientific OfficerSale2,658$21
Mar 17, 2026Cobb Stuart · officer: Chief Scientific OfficerSale148$22
Mar 17, 2026Cvijic Christine Mikail · officer: President and CFOSale2,387$20
Mar 3, 2026Cvijic Christine Mikail · officer: President and CFOSale4,800$25
Feb 24, 2026BAFFI ROBERT · directorA-Award12,050$18
Feb 24, 2026Cobb Stuart · officer: Chief Scientific OfficerA-Award16,500$0.00
Feb 24, 2026Jordan Julie · officer: Chief Medical OfficerA-Award4,900$0.00
Feb 24, 2026Jordan Julie · officer: Chief Medical OfficerA-Award29,600$18
Feb 24, 2026Cvijic Christine Mikail · officer: President and CFOA-Award22,000$0.00
Feb 24, 2026Cvijic Christine Mikail · officer: President and CFOA-Award131,900$18
Feb 24, 2026McMinn Rachel · director, officer: Chief Executive OfficerA-Award25,900$0.00
Feb 24, 2026McMinn Rachel · director, officer: Chief Executive OfficerA-Award155,100$18
Feb 24, 2026Woods Keith · directorA-Award12,050$18
Feb 24, 2026Freedland Cory S. · directorA-Award12,050$18
Institutional positioning

13F filings over the trailing two quarters

New 19Increased 47Reduced 16Sold out 95
FilerActionSharesFiled
SAMSARA BIOCAPITAL, LLCUnchanged1,717,127May 15, 2026
REDMILE GROUP, LLCUnchanged1,459,599May 15, 2026
CASDIN CAPITAL, LLCIncreased1,420,361May 15, 2026
RTW INVESTMENTS, LPUnchanged1,362,456May 15, 2026
ECOR1 CAPITAL, LLCUnchanged1,271,342May 15, 2026
BLACKROCK, INC.Increased1,005,070May 13, 2026
BAKER BROS. ADVISORS LPUnchanged991,691May 15, 2026
Trails Edge Capital Partners, LPReduced782,787May 15, 2026
BALYASNY ASSET MANAGEMENT L.P.Increased718,389May 15, 2026
TORONTO DOMINION BANKUnchanged681,337May 15, 2026
JENNISON ASSOCIATES LLCReduced527,685May 6, 2026
ARROWMARK COLORADO HOLDINGS LLCReduced524,796May 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position514,727May 15, 2026
GREAT POINT PARTNERS LLCIncreased500,000May 15, 2026
CITADEL ADVISORS LLCIncreased435,682Sep 2, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 7, 2026